Literature DB >> 14563748

Drug points: Weight loss associated with levetiracetam.

S Hadjikoutis1, T P Pickersgill, P E M Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563748      PMCID: PMC218814          DOI: 10.1136/bmj.327.7420.905

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Topiramate.

Authors:  T A Glauser
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

2.  Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures.

Authors:  E Faught; R Ayala; G G Montouris; I E Leppik
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

  2 in total
  4 in total

Review 1.  Pharmacotherapy for obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; John J McNeil
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Levetiracetam: a review of its use in epilepsy.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-03-05       Impact factor: 9.546

Review 3.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.

Authors:  Sudhir Chandra Sarangi; Manjari Tripathi; Ashish Kumar Kakkar; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.